Dear all, In case you are attending PAGE, and have not yet signed up for the free speed consulting with Pharmetheus, you are still most welcome to do so!
If there is anything you would like to discuss, feel free to set up a meeting with us, even if you have no plans to use our consultancy services later - this is open to everyone. Please use this link to get in contact with us for this matter: Pharmetheus.com/speed-consulting <http://pharmetheus.com/speed-consulting> Looking forward to seeing you at PAGE! Jakob Jakob Ribbing, Ph.D. Senior Consultant, Pharmetheus AB Cell/Mobile: +46 (0)70 514 33 77 jakob.ribb...@pharmetheus.com www.pharmetheus.com <http://www.pharmetheus.com/> Phone, Office: +46 (0)18 513 328 Uppsala Science Park, Dag Hammarskjölds väg 36B SE-752 37 Uppsala, Sweden > On 21 May 2019, at 10:36, Martin Bergstrand > <martin.bergstr...@pharmetheus.com> wrote: > > Free speed consulting with Pharmetheus at PAGE in Stockholm > > Due to its popularity last year, Pharmetheus will again offer free speed > consulting at the PAGE Meeting in Stockholm, Sweden. Pharmetheus will > offer professional pharmacometric consulting sessions (~30 min), free of > charge. Note that these sessions are open to everyone and independent of > any current or future plans to use our services. > Pharmetheus’ senior experts are available to give input on a wide range of > pharmacometric topics, offering strategic as well as hands-on assistance > concerning small as well as large molecules and drug projects in all > development phases. Examples of topics below (not limited to): > > - Study/experimental design (e.g. optimal design, clinical trial > simulations and adaptive design methodology) > - Pharmacometrics analysis methodology (e.g. covariate model building and > model qualification) > - Physiology based pharmacokinetics (PBPK) modelling > - Model-informed drug development (MIDD) strategy > - Regulatory strategy for clinical pharmacology and pharmacometric > analysis > - Pediatric drug development > - Data programming > - Pharmacometric approaches to analyse discreet data (e.g. time-to-event > and count data) > - Mechanism based PK modelling (e.g. enzyme induction/inhibition, target > mediated drug disposition and complex absorption) > - Mechanism based model building in therapeutic areas such as; > neuroscience, haematology, diabetes, oncology, inflammation, infectious > disease, respiratory disease and many more) > - Translational modelling (e.g. pre-clinical to clinical and adult to > paediatric populations) > - Career advice for junior pharmacometricians > - Pearl-Speaks-NONMEM (PsN) user support. Kajsa Harling, one of the main > developers of PsN, is available to answer your questions. > - R programming and reproducible reporting approaches > > If you want to read more about Pharmetheus’ consultants and their > respective competences, please visit our website www.pharmetheus.com/team. > Confidentiality agreements (CDA) will be arranged ahead of the meeting for > the discussions that need that. Just make sure to indicate this as you > sign up for a consultancy session on our website > http://www.pharmetheus.com/speed-consulting/. Note that if you judge a > confidential disclosure agreement (CDA) is required, this may require some > extra time to put in place ahead of the meeting. The deadline for > applications is the 3rd of June and time slots will be communicated by the > 10th of June. Please note that available time slots are limited. Sign up > as soon as possible to give us a chance to help you tackle your > challenges! > > We look forward to hear back from you, and to see you in Stockholm! > > The Pharmetheus Team > Pharmetheus AB > > +46(0)18 513 328 > www.pharmetheus.com > Uppsala Science Park > Dag Hammarskjölds väg 36b, 2 tr > 75237 Uppsala, Sweden >
